EP2649997

(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    10.12.2008
  • :
    23.1.2019
  • :
    13166632.3
  • :
    9.12.2028
  • :
    (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome

10.12.2008
23.1.2019
  • :
    Sunesis Pharmaceuticals, Inc.
  • :
    395 Oyster Point Boulevard, Suite 400, 94080, South San Francisco, CA, US
  • :
    Michelson, Glenn
  • :
    San Francisco, CA California, US
  • :
    7229 P
  • :
    10.12.2007
  • :
    US
  • :
    A61K 31/4375, A61K 31/513, A61P 35/02, A61K 45/06, A61K 31/53